Peter Ordentlich, Chief Scientific Officer at Syndax Pharmaceuticals Inc (SNDX), sold 59,944 shares at $23.33 ($1.4M) on 2020-11-23, disclosed to the SEC on 2020-11-25.
Open-market sale of $1.4M SNDX by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.89 | 16,334 | $374K | 26.9% |
| 2 | $22.89 | 16,334 | $374K | 26.9% |
| 3 | $23.33 | 5,684 | $133K | 9.6% |
| 4 | $23.33 | 5,684 | $133K | 9.6% |
| 5 | $23.58 | 7,954 | $188K | 13.5% |
| 6 | $23.58 | 7,954 |
| $188K |
| 13.5% |
| Total | $23.16 avg | 59,944 | $1.4M | 100% |
| Filing → |
| SNDX | SELL | 2022-12-02 | $821K | — | Filing → |
| SNDX | SELL | 2022-08-26 | $1.3M | — | Filing → |
| SNDX | SELL | 2022-02-03 | $24K | — | Filing → |